Mismatch repair system proteins in oral benign and malignant lesions

Journal of Oral Pathology and Medicine

Volumn 46, Issue 4, 2017, Pages 241-245

  Amaral Silva, Gleyson Kleber do ^a   Martins, Manoela Domingues ^b   Pontes, Hélder Antônio Rebelo ^c   Fregnani, Eduardo Rodrigues ^d   Lopes, Márcio Ajudarte ^a   Fonseca, Felipe Paiva ^a   Vargas, Pablo Agustin ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

leukoplakia; mismatch repair system; MLH; MSH; MutL; MutS; oral cancer

Indexed keywords

MISMATCH REPAIR PROTEIN; PROTEIN MUTS;

DISEASE ASSOCIATION; HUMAN; LIP CANCER; MISMATCH REPAIR; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; LIP TUMOR; METABOLISM; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; DNA MISMATCH REPAIR; HUMANS; LIP NEOPLASMS; MOUTH NEOPLASMS; MUTS PROTEINS;

EID: 84994577560     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12484     Document Type: Review

References (44)

1. Ribezzo F, Shiloh Y, Schumacher B. Systemic DNA damage responses in aging and diseases. Semin Cancer Biol 2016; 37–38: 26–35.
2. Loeb LA, Cheng KC. Errors in DNA synthesis: a source of spontaneous mutations. Mutat Res 1990; 238: 297–304.
3. Preston BD, Albertson TM, Herr AJ. DNA replication fidelity and cancer. Semin Cancer Biol 2010; 20: 281–93.
4. Johnson SJ, Beese LS. Structures of mismatch replication errors observed in a DNA polymerase. Cell 2004; 116: 803–16.
5. Hsieh P, Yamane K. DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech Ageing Dev 2008; 129: 391–407.
6. Modrich P, Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 1996; 65: 101–33.
7. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999; 9: 89–96.
8. Lipkin SM, Wang V, Jacoby R, et al. MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability. Nat Genet 2000; 24: 27–35.
9. Clark N, Wu X, Her C. MutS homologues hMSH4 and hMSH5: genetic variations, functions, and implications in human diseases. Curr Genomics 2013; 14: 81–90.
10. Modrich P. Mechanisms in eukaryotic mismatch repair. J Biol Chem 2006; 281: 30305–9.
11. Erie DA, Weninger KR. Single molecule studies of DNA mismatch repair. DNA Repair (Amst) 2014; 20: 71–81.
12. Peltomäki P. Lynch syndrome genes. Fam Cancer 2005; 4: 227–32.
13. Naqvi RA, Hussain A, Deo SS, et al. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women. Hum Pathol 2008; 39: 672–80.
14. Dominguez-Valentin M, Joost P, Therkildsen C, Jonsson M, Rambech E, Nilbert M. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome. BMC Urol 2016; 16: 15.
15. Ehsani L, Osunkoya AO. Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis. Tumour Biol 2014; 35: 8743–7.
16. Slováková P, Majerová L, Matáková T, Skereňová M, Kavcová E, Halašová E. Mismatch repair gene polymorphisms and association with lung cancer development. Adv Exp Med Biol 2015; 833: 15–22.
17. Caldeira PC, Abreu MHNG, Batista AC. DO CARMO MAV. hMLH1 immunoexpression is related to the degree of epithelial dysplasia in oral leukoplakia. J Oral Pathol Med 2011; 40: 153–9.
18. Caldeira PC, Aguiar MCF, Mesquita RA. DO CARMO MAV. Oral leukoplakias with different degrees of dysplasia: comparative study of hMLH1, p53, and AgNOR. J Oral Pathol Med 2011; 40: 305–11.
19. Jessri M, Dalley AJ, Farah CS. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119: 74–82.
20. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer 2007; 109: 703–12.
21. Fernandes AM, de Souza VRDC, Springer CRA, et al. Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. Anticancer Res 2007; 27: 2433–7.
22. Sarmento DJS, de Almeida WL, Miguel MCC, et al. Immunohistochemical analysis of mismatch proteins in carcinogenesis of the lower lip. Histopathology 2013; 63: 371–7.
23. de Oliveira DHIP, de Sousa Lopes MLD, de Santana Sarmento DJ, Queiroz LMG, da Costa Miguel MC, da Silveira EJD. Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis. J Oral Pathol Med 2014; 43: 357–63.
24. Souza LR, Fonseca-Silva T, Pereira CS, et al. Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma. Histopathology 2011; 58: 352–60.
25. Jessri M, Dalley AJ, Farah CS. hMSH6: a potential diagnostic marker for oral carcinoma in situ. J Clin Pathol 2015; 68: 86–90.
26. Pontes FSC, Carneiro JT, Fonseca FP, da Silva TSP, Pontes HAR, Pinto DS. Squamous cell carcinoma of the tongue and floor of the mouth. J Craniofac Surg 2011; 22: 925–30.
27. Lo Muzio L, Nocini P, Mignogna MD, et al. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. Anticancer Res 1999; 19: 933–40.
28. Helal TEA, Fadel MT, El-Thobbani AK, El-Sarhi AM. Immunoexpression of p53 and hMSH2 in oral squamous cell carcinoma and oral dysplastic lesions in Yemen: relationship to oral risk habits and prognostic factors. Oral Oncol 2012; 48: 120–4.
29. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Oral Dis 2009; 15: 206–13.
30. González-Ramírez I, Ramírez-Amador V, Irigoyen-Camacho ME, et al. hMLH1 promoter methylation is an early event in oral cancer. Oral Oncol 2011; 47: 22–6.
31. Tawfik HM, El-Maqsoud NMRA, Hak BHAA. EL-SHERBINY YM. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Am J Otolaryngol 2011; 32: 528–36.
32. Wang Y, Irish J, Macmillan C, et al. High frequency of microsatellite instability in young patients with head-and-neck squamous-cell carcinoma: lack of involvement of the mismatch repair genes hMLH1 AND hMSH2. Int J Cancer 2001; 93: 353–60.
33. Jha R, Gaur P, Sharma SC, Das SN. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Gene 2013; 526: 223–7.
34. Mondal P, Datta S, Maiti GP, et al. Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer. PLoS One 2013; 8: e56952.
35. Nogueira GAS, Lourenço GJ, Oliveira CBM, et al. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma. Int J Cancer 2015; 137: 810–8.
36. Fujieda S, Tanaka N, Sunaga H, et al. Expression of hMSH2 correlates with in vitro chemosensitivity to CDDP cytotoxicity in oral and oropharyngeal carcinoma. Cancer Lett 1998; 132: 37–44.
37. Adachi M, Ijichi K, Hasegawa Y, Nakamura H, Ogawa T, Kanematsu N. Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells. Exp Ther Med 2010; 1: 93–6.
38. Wagner VP, Webber LP, Salvadori G, et al. Overexpression of MutSα complex proteins predicts poor prognosis in oral squamous cell carcinoma. Medicine (Baltimore) 2016; 95: e3725.
39. Korabiowska M, Brinck U, Ruschenburg I, Honig JF, Stachura J, Droese M. Loss of DNA-mismatch repair gene expression in oral melanomas. Oncol Rep 1999; 6: 921–3.
40. Lo Muzio L, Nocini P, Mignogna MD, et al. Immunocytochemical detection of hMSH2 and hMLH1 expression in oral melanoma. Anticancer Res 2000; 20: 741–8.
41. Tobón-Arroyave SI, Flórez-Moreno GA, Jaramillo-Cárdenas JF, et al. Expression of hMLH1 and hMSH2 proteins in pleomorphic adenoma of minor salivary glands: relationship with clinical and histologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 227–36.
42. Ohki K, Kumamoto H, Ichinohasama R, et al. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins. Int J Oral Maxillofac Surg 2001; 30: 538–44.
43. Castrilli G, Fabiano A, la Torre G, et al. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors. J Oral Pathol Med 2002; 31: 234–8.
44. Castrilli G, Piantelli M, Artese L, et al. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J Oral Pathol Med 2001; 30: 305–8.